Ten healthy, recreationally resistance-trained men [regular (i.e. thrice weekly) for at least 1 year], who had a mean ± SD body mass of 90 ± 18.2 kg, height 1.79 ± 0.06 m, age 21.6 ± 2.27 yr, 5.98 ± 1.55 leg press strength-to-body weight ratio, and body fat 21.3 ± 8.1%, participated in this study. Only participants considered low risk for cardiovascular disease with no contraindications to exercise outlined by the American College of Sports Medicine, and who had not consumed any nutritional supplements (excluding multi-vitamins) one month prior to the study could participate. This study was approved by the Institutional Review Board for Human Subjects at Baylor University. Additionally, all experimental procedures involved in the study conformed to the ethical consideration of the Declaration of Helsinki. Participants were familiarized to the study protocol via a verbal and written explanation outlining the study design and then read and signed a university-approved informed consent document. In addition, each participant was instructed to refrain from exercise for 48 hours before each testing session, eat a light, low carbohydrate meal 3 hours prior to reporting for each testing session, and record their dietary intake for two days (including the light meal the morning of testing) prior to each of the three testing sessions. Diets were not standardized but participants were asked not to change their dietary habits. The MyFitnessPal mobile application (Under Armor Inc., Baltimore, MD, USA) was used to determine the average daily macronutrient consumption of fat, carbohydrate, and protein. Participants completed a medical history questionnaire and underwent a general physical examination to determine whether they further met eligibility criteria. At session 2, participants performed angled leg press one-repetition maximum (1-RM) tests with the National Strength and Conditioning Association (NSCA) recommendations (Moir, 2010). Foot placement was recorded and held constant over all testing conditions. A goniometer was used to establish 90° of knee flexion while positioned on the leg press machine and safety catches were adjusted just below this point for all tests to standardize the range of motion to 90°. The participants were instructed to lower the weight just above the catches before pressing the weight upward. Participants warmed up with 10 repetitions at approximately 50% estimated 1-RM, rested 1 minute, and completed 5 repetitions at approximately 70% estimated 1-RM followed by 2 minutes rest. The weight was then increased conservatively, and the participants attempted the first 1-RM. If the lift was successful, the participant rested for 2 minutes before attempting the next 1-RM. The 1-RM of each participant was compared to male 90% rank normative values of age specific strength-to-body weight ratios (2.27) (Hoffman, 2007). This substantiated that all participants were trained for at least a year as stated in the exercise questionnaire. Thirty minutes following the 1-RM test, participants completed 4 sets of maximal repetitions as outlined in the resistance exercise protocol. During testing sessions 3 and 4, participants completed a warm-up set of 10 repetitions and 5 repetitions at 50% and 70% of the testing load, respectively. Each set was followed by two minutes of rest and then the exercise testing session began. Participants performed 4 sets of repetitions to volitional fatigue with 70% of the 1-RM on the angled leg press. A 45-second rest interval was provided between sets. When the subject was not able to perform another repetition in the set, study personnel assisted to help re-rack the weight safely. The total number of repetitions performed at each testing session was recorded. At session 3 and 4, 30 minutes before resistance exercise, in a randomized, doubled-blind fashion, participants ingested either a placebo or a carbohydrate supplement. The 30min time point was selected in an attempt to maximize the bio-available glucose in the blood that could be used at the onset of exercise (Pannoni, 2011). The placebo consisted of a flavored, non-caloric beverage [(Crystal Light) Kraft Foods, Chicago, IL, USA] mixed with water and orally ingested. The carbohydrate supplement was maltodextrin (Carbo Gain, NOW Sports, Bloomingdale, IL, USA) at a dose of 2 g/kg body mass, mixed with Crystal Light in water, and orally ingested (Wax et al., 2012). Both supplements were of similar color, taste, volume, and consistency. A period of 7 to 10 days separated sessions 3 and 4 to allow for adequate supplement washout and muscle recovery. Venous blood samples were obtained from an antecubital vein into 10 ml vacutainer tubes before supplement ingestion, immediately before resistance exercise (30 minutes following supplement ingestion), immediately post-exercise, and 1-hr post exercise. Blood samples stood at room temperature for 10 minutes and then centrifuged at 2500 rpm. The serum was removed and frozen at -80°C for later analysis. Blood was drawn into microhematocrit tubes (in duplicate) by capillary action and sealed with a clay material. The microhematocrit tube was placed into the centrifuge, balanced, spun for 2 minutes, then removed and read on a hematocrit reader card. Normal ranges in adult males are between 42-52% and over 54% was considered dehydrated and rehydration was required before further testing (Pagana and Pagana, 2013). Three percutaneous muscle biopsies (~30 mg each) were completed at visits 3 and 4 using fine needle aspiration upon entry, immediately post-exercise, and 1hr post-exercise. Biopsies were obtained from the middle portion of the vastus lateralis muscle of the dominant leg at the midpoint between the patella and the greater trochanter of the femur at a depth between 1 and 2 cm. After the initial biopsy, remaining biopsies attempts were made to extract tissue from approximately the same location as the initial biopsy using the pre-biopsy scar, depth markings on the needle, and a successive puncture was made approximately 0.5 cm from medial to lateral. Adipose tissue was trimmed, and muscle specimens were immediately stored at -80°C for later analysis. Serum glucose (Cayman Chemical, Ann Arbor, MI, USA) and muscle glycogen (BioVision, Milpitas, CA, USA) were assessed with colorimetric assays and absorbances read at wavelengths of 514 and 570 nm, respectively. Serum insulin (Cayman Chemical, Ann Arbor, MI, USA) and epinephrine (MyBioSource, San Diego, California, USA) concentrations were determined using a commercially-available enzyme-linked immunosorbent assay kits and absorbances were read at wavelengths of 414 nm and 450 nm, respectively. The absorbances of all serum variables were determined with a microplate reader (X-Mark, Bio-Rad, Hercules, CA, USA) and concentrations determined by linear regression against known standard curves using commercial software (Microplate Manager, Bio-Rad, Hercules, CA, USA). In addition, all samples were assayed in duplicate to ensure reliability of the assay results. The statistical analysis for performance between supplement conditions was completed using a 2 x 4 [Condition (CHO, Placebo) x Set (1,2,3,4)] factorial analyses of variance (ANOVA) with repeated measures for reps to fatigue. Statistical analyses for blood concentrations were performed by utilizing separate 2 x 4 [Condition (CHO, Placebo) x Time (Pre, post-consumption, post-exercise, 1-hr post-exercise)] factorial ANOVA with repeated measures for serum glucose and insulin. The 2 x 4 [Condition (CHO, Placebo) x Time (Pre, post-consumption, post-exercise, 1-hr post-exercise)] factorial ANOVA for epinephrine could not be run due to the test assumptions of normality being violated. The outliers (> ± 2sd) were removed meeting the needed assumptions for the ANOVA; however, this created a statistical difference between baseline values in supplement conditions. To assess the differences in concentrations accounting for baseline differences between conditions, a 2 x 3 [Condition (CHO, Placebo) x Baseline Change (Pre-Supplement, post-exercise, 1-hr post-exercise)] factorial ANOVA with repeated measures was completed. Muscle glycogen concentration analysis was performed by utilizing a 2 x 3 [Condition (CHO, Placebo) x Time (Baseline, post-exercise, 1-hr post-exercise)] factorial ANOVA with repeated measures. If a significant interaction was found, simple effects analysis was conducted to determine where the interaction occurred. If a significant interaction was present, analysis of main effects was conducted using the simple effects, pairwise comparisons with a Bonferroni adjustment to compare dependent variables within each independent variable condition. If no interaction was present, then normal pairwise comparisons with a Bonferroni adjustment were used to test main effects. Partial Eta squared (η2), was used to estimates the proportion of variance in the dependent variable explained by the independent variable. Partial Eta squared effect sizes determined to be: weak = 0.17, medium = 0.24, strong = 0.51, very strong = 0.70. For all statistical analyses, an alpha level of 0.05 was adopted throughout. |